Research Articles
TACC3: The Hidden Puppeteer in Lung Cancer's Immune Escape
Exploring the role of TACC3 protein in lung adenocarcinoma prognosis and immune system evasion. Discover how this biomarker influences cancer treatment and patient outcomes.
Cellular Espionage: Decoding the Silent Conversation Between Cancer and Immune Cells
Discover how HySic technology enables scientists to decode the molecular conversation between tumor cells and T cells, advancing cancer immunotherapy research.
Unlocking the Secrets of Cancer Immunity: How a Micro-Lab on a Chip is Revolutionizing Cancer Research
Discover how the Dexter microfluidic platform is transforming cancer research by enabling unprecedented observation of tumor-immune interactions in microdroplets.
The Hypoxia-Immune Signature: Decoding Cancer's Stealth Tactics to Predict Patient Survival
Discover how a novel 8-gene signature combining hypoxia and immune regulation predicts survival across six cancer types, starting with liver cancer.
Turning Cold Tumors Hot: How a Blood Cancer Drug Could Revolutionize Prostate Cancer Treatment
Discover how ibrutinib, a blood cancer drug, is being repurposed to make prostate cancer responsive to immunotherapy by targeting tumor-infiltrating B cells.
The Silent Allies Within: How Our Microbiome is Revolutionizing Cancer Treatment
Exploring how our microbiome influences cancer development and treatment response, with breakthrough research on microbial modulation of immunotherapy.
The Neoantigen Revolution: How NEO-STIM™ Is Supercharging Cancer's Most Wanted Immune Cells
Breakthroughs in NEO-STIM™, an ex vivo T-cell training protocol, are creating armies of tumor-targeted assassins by harnessing neoantigens - cancer's unique molecular fingerprints.